[
  {
    "ts": null,
    "headline": "Amgen : 43rd Annual JP Morgan Healthcare Conference Presentation",
    "summary": "43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE ROBERT A. BRADWAY, CHAIRMAN AND CHIEF EXECUTIVE OFFICER January 13, 2025 ...",
    "url": "https://finnhub.io/api/news?id=ea1c2813d0a1d609622f6184863989f98a17a7956d8af7bf73f2b1cc85fcd9f0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736803805,
      "headline": "Amgen : 43rd Annual JP Morgan Healthcare Conference Presentation",
      "id": 132390662,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE ROBERT A. BRADWAY, CHAIRMAN AND CHIEF EXECUTIVE OFFICER January 13, 2025 ...",
      "url": "https://finnhub.io/api/news?id=ea1c2813d0a1d609622f6184863989f98a17a7956d8af7bf73f2b1cc85fcd9f0"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)",
    "summary": "Amgen Inc. (NASDAQ:AMGN) 43rd Annual J.P.",
    "url": "https://finnhub.io/api/news?id=de747f34ffee3e71d97cddda0ddafce6d4b1cbebbcc4755e0251ba1e77760790",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736800616,
      "headline": "Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)",
      "id": 132390494,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen Inc. (NASDAQ:AMGN) 43rd Annual J.P.",
      "url": "https://finnhub.io/api/news?id=de747f34ffee3e71d97cddda0ddafce6d4b1cbebbcc4755e0251ba1e77760790"
    }
  },
  {
    "ts": null,
    "headline": "43rd Annual J.P. Morgan Healthcare Conference 2025",
    "summary": "The following slide deck was published by Amgen Inc.",
    "url": "https://finnhub.io/api/news?id=b420947326166dbf4d9541ee3048e7accd9998d6a310e1ed5cd157b72d5ae42d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736795665,
      "headline": "43rd Annual J.P. Morgan Healthcare Conference 2025",
      "id": 132390260,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Amgen Inc.",
      "url": "https://finnhub.io/api/news?id=b420947326166dbf4d9541ee3048e7accd9998d6a310e1ed5cd157b72d5ae42d"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
    "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
    "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736791802,
      "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
      "id": 132390023,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168184/image_1886168184.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
      "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Caterpillar share gains lead Dow's 350-point climb",
    "summary": "UnitedHealth, Caterpillar share gains lead Dow's 350-point climb",
    "url": "https://finnhub.io/api/news?id=a31a5666bf320ec51ebd89c83bca7ff5697050ab27c74dfe8c69cf229e8f5f8b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736783580,
      "headline": "UnitedHealth, Caterpillar share gains lead Dow's 350-point climb",
      "id": 132407802,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Caterpillar share gains lead Dow's 350-point climb",
      "url": "https://finnhub.io/api/news?id=a31a5666bf320ec51ebd89c83bca7ff5697050ab27c74dfe8c69cf229e8f5f8b"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
    "summary": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
    "url": "https://finnhub.io/api/news?id=acefd6c62b5e03c69f1a52f64769dcd68743f1fbdf4f7407acb14bb7b9c5ad1f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736773140,
      "headline": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
      "id": 132407804,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
      "url": "https://finnhub.io/api/news?id=acefd6c62b5e03c69f1a52f64769dcd68743f1fbdf4f7407acb14bb7b9c5ad1f"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
    "summary": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
    "url": "https://finnhub.io/api/news?id=37e2a928d2167d0048035cc98a3a4b5233aa2bc53c699711f8e55cded28f8379",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736765823,
      "headline": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
      "id": 132407688,
      "image": "",
      "related": "AMGN",
      "source": "DowJones",
      "summary": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
      "url": "https://finnhub.io/api/news?id=37e2a928d2167d0048035cc98a3a4b5233aa2bc53c699711f8e55cded28f8379"
    }
  },
  {
    "ts": null,
    "headline": "SpringWorks: PDUFA Review Date Could Lead To Next Approved Pipeline Candidate",
    "summary": "SpringWorks has shown strong revenue growth with OGSIVEO, achieving a 23% increase from Q2 of 2024 to Q3 of 2024. See why I rate SWTX stock a strong buy.",
    "url": "https://finnhub.io/api/news?id=8a4833b7c0dbcdf2a59ef3d7d12e8877cadca798aa4e02c468e92d343c93357c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736747815,
      "headline": "SpringWorks: PDUFA Review Date Could Lead To Next Approved Pipeline Candidate",
      "id": 132386392,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2177260462/image_2177260462.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "SpringWorks has shown strong revenue growth with OGSIVEO, achieving a 23% increase from Q2 of 2024 to Q3 of 2024. See why I rate SWTX stock a strong buy.",
      "url": "https://finnhub.io/api/news?id=8a4833b7c0dbcdf2a59ef3d7d12e8877cadca798aa4e02c468e92d343c93357c"
    }
  }
]